Medicare Reimbursement for iStent Trabecular Micro-Bypass Stent

FREQUENTLY ASKED QUESTIONS: 

MEDICARE REIMBURSEMENT FOR iSTENT TRABECULAR MICRO-BYPASS STENT

© Corcoran Consulting Group

Download as PDF

For best results, please view in Mozilla Firefox

 

Q  What is the iStent® trabecular micro-bypass system?

iStent® is a small (1 mm X 0.33 mm) device designed to fit into Schlemm’s canal to facilitate aqueous drainage from the anterior chamber.  It is made of non-magnetic, surgical grade titanium; it is coated with heparin and comes preloaded in an inserter.  There are two different orientations of iStent – one for each eye.1.

 

Q  What are the indications for iStent?

A  As approved by the FDA on June 25, 2012, the iStent “…is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild or moderate open-angle glaucoma currently treated with ocular hypotensive medication.2.  The FDA also noted that “This option may be considered earlier in the disease process than some other types of surgical glaucoma treatments.3.

 

Q  Is iStent indicated for patients with glaucoma in the absence of cataract?

A  No.  The FDA approval specifies “in combination with cataract surgery”.  All other uses are “off-label” and experimental or investigational.  As a general rule, third party payers do not cover experimental and investigational procedures.

 

Q  What CPT code describes implantation of iStent?

A  A category III CPT code, 0191T, established on July 1, 2008, applies.  It reads: “Insertion of anterior segment aqueous drainage device, without extraocular reservoir; internal approach, into the trabecular meshwork.”

 

Q  Does Medicare cover this procedure?

A  Yes, all Medicare Administrative Contractors (MACs) cover this procedure when medically necessary.  Check your local MAC for specific reimbursement information.

 

Q  Do commercial payers cover the iStent?

A  Yes, some commercial payers4. cover the iStent.  It is recommended that prior authorization be obtained prior to scheduling a procedure whenever possible.

 

Q  What is the global period for 0191T?

A  As a Category III code, there is no specified global period for 0191T.  The global period for concurrent cataract surgery is 90 days.  As a practical matter, the known interval outweighs the unknown interval.

 

Q  What does the Medicare fee schedule say for 0191T?

A  Payment rates vary by type of provider and site of service.  In 2014, the Medicare allowed amounts are:

  • Physician ………………… MAC discretion
  • ASC Facility Fee …………….. $1,677.90
  • HOPD Facility Fee …………… $3,037.37

Because the known values are higher than the allowed amounts for the concurrent cataract surgery, 0191T ought to be the primary procedure.  These amounts are adjusted in each locality by local wage indices and are additionally subject to payer restrictions which can vary considerably.

 

Q  Is there separate Medicare reimbursement for the iStent device?

A  No.  Medicare payment for the iStent glaucoma drainage device is included in the facility reimbursement for APC 0673.  On UB-04 claims, use revenue code 278, together with 0191T, to report the iStent.  For other payers, check your contract with respect to prosthetic devices.

 

Q  What about implanting two iStents in the same eye during the same operation?

A  This question needs to be addressed by further clinical studies, now underway.  The Directions for Use state that a single iStent per eye should be used.

 

Q  How should we bill if one surgeon removes the cataract and another implants the iStent?

A  If both surgeons are part of the same group, then only a single claim is needed and the aggregate payment is made to the group.  When the surgeons are not part of the same group, then separate claims are required.

 

Q  Are there any NCCI edits or bundles for CPT 0191T?

A  Yes; as of January 1, 2014, NCCI edits include, as expected, 66170, 66172, 66180 and 0192T.  Some other edits apply as well.  In addition, all edits in place for the concurrent cataract procedure pertain.

Check NCCI edits periodically as they may change quarterly.  Most third party payers follow NCCI edits, but not all.  Check your payer contracts.

 

Q  May gonioscopy be billed at the time of iStent implantation?

A  No.  Gonioscopy (CPT 92020) is required to implant the iStent.  Because gonioscopy carries the “separate procedure” designation in CPT, it should not be billed when it is integral to the performance of another procedure.

 

1.  Glaukos (Manufacturer) website.  Link here.

2.  iStent Directions for Use.  Link here.

3.  FDA News Release June 25, 2012.  Link here.

4.  Favorable payers include Aetna, Cigna, UHC

 

Last updated May 2, 2014

 

The reader is strongly encouraged to review federal and state laws, regulations, code sets (including ICD-9 and ICD-10), and official instructions promulgated by Medicare and other payers.  This document is not an official source nor is it a complete guide on reimbursement.  The reader is reminded that this information, including references and hyperlinks, changes over time, and may be incorrect at any time following publication.

 

© 2014 Corcoran Consulting Group.   All rights reserved.  No part of this publication may be reproduced or distributed in any form or by any means, or stored in a retrieval system, without the written permission of the publisher.

 

Corcoran Consulting Group    (800) 399-6565   www.corcoranccg.com

Website by MIC